Clinical Hematology International

Volume 2, Issue 4, December 2020, Pages 173 - 175

COVID-19 in Hematologic Malignancies: Big Challenges

Authors
Yongxian Hu1, 2, 3, Linqin Wang1, 2, 3, ORCID, Qu Cui4, Elaine Tan Su Yin1, 2, 3, Hengwei Wu1, 2, 3, Arnon Nagler5, He Huang1, 2, 3, *
1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
3Institute of Hematology, Zhejiang University, Hangzhou, China
4Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
5Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
*Corresponding author. Email: huanghe@zju.edu.cn
Corresponding Author
He Huang
Received 29 May 2020, Accepted 16 September 2020, Available Online 7 October 2020.
DOI
https://doi.org/10.2991/chi.k.200919.001How to use a DOI?
Keywords
COVID-19; hematological malignancies; clinical manifestation; treatment strategies
Copyright
© 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Clinical Hematology International
Volume-Issue
2 - 4
Pages
173 - 175
Publication Date
2020/10/07
ISSN (Online)
2590-0048
DOI
https://doi.org/10.2991/chi.k.200919.001How to use a DOI?
Copyright
© 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - JOUR
AU  - Yongxian Hu
AU  - Linqin Wang
AU  - Qu Cui
AU  - Elaine Tan Su Yin
AU  - Hengwei Wu
AU  - Arnon Nagler
AU  - He Huang
PY  - 2020
DA  - 2020/10/07
TI  - COVID-19 in Hematologic Malignancies: Big Challenges
JO  - Clinical Hematology International
SP  - 173
EP  - 175
VL  - 2
IS  - 4
SN  - 2590-0048
UR  - https://doi.org/10.2991/chi.k.200919.001
DO  - https://doi.org/10.2991/chi.k.200919.001
ID  - Hu2020
ER  -